Mark Fischer-Colbrie

Former CEO Labcyte, Strateos. Bus Dev / CFO Adeza Biomedical. Board, Center for Regenerative Medicine (CIRM). Past Chair, JDRF. 13 yr. Board, ALDA

[Breakthrough T1D UK @BT1DUK]

🚨 Exciting cure research news! 🚨

Clinical trials of lab-grown islets in the US have moved into phase 3, which is the final stage of the clinical trials process aimed at gathering data for regulatory approval.

This is first time a treatment to cure type 1 diabetes has reached this stage! 🌟

Find out more 👇

[Breakthrough T1D @BreakthroughT1D]

Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes.

This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase.

Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring.

Learn more here: https://t.co/g3XuCpqZ4V

[Karen Addington @KarenFAddington]

.@aaronjkowalski speaking at @BreakthroughT1D @BT1DUK #MissionSummit2024 talks about how important our international collaboration is to find cures for #Type1Diabetes #T1D

[Karen Addington @KarenFAddington]

It was such a pleasure to have the opportunity to introduce our @BT1DUK @BreakthroughT1D Global Research Ambassador @theresa_may and welcome her to the stage with @aaronjkowalski at the opening dinner of Mission Summit last night

[California Institute for Regenerative Medicine @CIRMnews]

The @ucdavis Alpha Clinic is celebrating a huge milestone: administering its 500th investigational product!

Karen O'Donnell, a cell and gene therapy specialist at UC Davis, stated: "For me, the administration of 500 investigational products represents 500 moments of hope..."

[California Institute for Regenerative Medicine @CIRMnews]

CIRM announced key recommendations from its Strategic Allocation Framework (SAF), a structured and data-driven effort designed to prioritize resources and maximize the impact of CIRM’s funding.

Learn more at https://t.co/9WzWZZpPeZ

#CIRM #Update #RegenerativeMedicine

[Breakthrough T1D @BreakthroughT1D]

Our thoughts are with all those who have been impacted by #HurricaneHelene.

If you, or someone you know, lives with type 1 diabetes (T1D) and needs resources or support, visit the link below.

https://t.co/9Np1XBKztk

[Insulin for Life USA @Insulin4LifeUSA]

Have excess diabetes supplies? It’s easy to donate! Just follow these four steps!

[Breakthrough T1D UK @BT1DUK]

🌟 We’re delighted to have supported the creation of the new Type 1 Diabetes in Schools Training Platform! 🌟

It provides essential information and awareness about type 1 for school teachers and staff.

Share the link with your school to support the training of primary and secondary school staff: https://t.co/V5xFWAGBS5

@DigiBeteUK @DiabetesUK

#GBDoc #Type1Diabetes #T1D

[Insulin for Life USA @Insulin4LifeUSA]

Keeping insulin cool while it’s on the move is our top priority! This is how we’ve sent out 1.6 million units of insulin this year!

[Insulin for Life USA @Insulin4LifeUSA]

IFL’s disaster response sometimes goes beyond the initial event. We have sent supplies to support the diabetes community in Ukraine since 2022. Your donations help us support our existing, consistent partners while we respond to emergency situations around the world.

[Josie Clarkson @JosieClarkson8]

A fascinating #EASD2024 talk by @SarahIBEx on her #research funded by the #Type1DiabetesGrandChallenge 👏

The #T1D Grand Challenge is a £50m partnerships between @JDRFUK, @DUK_research and @stevemorganfdn and part of this is funding work to understand the root causes of T1D.

[California Institute for Regenerative Medicine @CIRMnews]

#CIRM has allocated $26M to support #ClinicalResearch targeting #cancers, #HeartConditions, and #RareDiseases. This funding supports five projects within CIRM’s Clinical program.

https://t.co/hqmfnuyDh9

[Breakthrough T1D UK @BT1DUK]

Smart insulins research #news 🔬

JDRF-funded #research has shown a new type of oral insulin can detect rising blood glucose and quickly lower it to a safe level in animal models of #Type1Diabetes without causing hypos.

📰 Learn more: https://t.co/6ayOmXEm94

[Tom Baiga @BaigaTom]

@jrkelly @Ginkgo looks tight. 💪
grew up on Gilson and CRS. Then onto way to Cavro & Tecan. Then came Velocity 11, Hamilton and finally HighResBio. But my favorite tool to this day is Labcyte ECHO...so much untapped potential still to be unlocked there. @Mdfctri09 MFC & Rich Ellson GOATs!

[Mark Anderson @MAndersonUCSF]

Scientists Get to the Bottom of COVID’s Worst Pediatric Complication https://t.co/FpVCdAXyJ7

[Mark Fischer-Colbrie @Mdfctri09]

Great work!

[Mark Anderson @MAndersonUCSF]

Proud of our team that unlocked this terrible complication of COVID-19 in children. @AtUcsf @UCSF @immunox

https://t.co/cDBFrRYvLh

[Jay Bradner, M.D. @jaybradner]

Today in @ScienceMagazine, together with my former colleagues at NIBR, we report the discovery and characterization of first molecular glue degraders of the WIZ transcription factor (TF) for fetal hemoglobin derepression and therapeutic consideration in Sickle Cell Disease. 1/10
https://t.co/rJypcBl75C

[Mark Fischer-Colbrie @Mdfctri09]

So well deserved!!

[Mark Anderson @MAndersonUCSF]

Honored and thrilled for this recognition

[Breakthrough T1D @BreakthroughT1D]

We are thrilled to see these promising results from Vertex Pharmaceuticals’ clinical trial of VX-880, a groundbreaking, stem cell-derived islet cell therapy for people living with type 1 diabetes (T1D). Learn more here: https://t.co/ij3xOgA28p